10,10-二吡啶甲基-9,10-二氢蒽的合成研究

蒽酮1和氯甲基吡啶盐酸盐2在甲苯中回流反应生成10,10-二吡啶甲基-9(10H)蒽酮(3),收率63％～68％;3用硼氢化钠还原生成10,10-二吡啶甲基-9,l0-二氢蒽-9-醇(4),收率87％～90％;蒽醇4在酸催化下发生歧化反应,得到还原产物10,10-二吡啶甲基-9,10-二氢蒽(5)和氧化产物蒽酮3.该歧化反应受催化剂、溶剂和反应温度等影响.当蒽醇4用三氟化硼为催化剂、甲苯为溶剂、回流反应,5的收率达到74％.所合成的新化合物都经1H NMR,13C NMR,MS和元素分析表征确认.     

对苯二亚甲基联二高三蝶烯的合成

报道了一种从蒽酮出发制备对苯二亚甲基联二高三蝶烯的合成方法. 以蒽酮为原料, 经缩合、加氢还原以及Williamson烷基化反应得到一系列的联二蒽酮衍生物10e, 12f～12h. 受其10位取代基等因素的影响, 12f～12g在NaBH₄还原和酸催化条件下发生选择性的1,7-跨环脱水成环反应, 高产率地得到了联二高三蝶烯14f～14g. 在相同条件下, 10e和12h却发生了1,4-脱水和重排反应生成了联二蒽衍生物15i～15j, 而不是预期的螺环类联二高三蝶烯产物16i～16j. 另外, 在制备过程中还得到了一些结构新颖的副产物如蒽醇过氧化物5a～5c, 以及蒽醚酮类衍生物11a, 13a等.     

新型含2-喹诺酮基的氧杂蒽二酮衍生物的合成

以醋酸为催化剂,DMF为溶剂,取代-2-氯喹啉-3-甲醛和5,5-二甲基-1,3-环己二酮于80 ℃~100 ℃反应2.5 h~4．0 h,合成了5个新型的含2-喹诺酮基的氧杂蒽二酮衍生物,收率78%~90%,其结构经¹H NMR, IR, HR-ESI-MS和元素分析表征。3,3,6,6-四甲基-9-{3-［7-甲基喹啉基-2(1H)酮］}-2,4,5,7,9,10-六氢化氧杂蒽-1,8(2H,5H)二酮（3b）经X-射线单晶衍射表征。 3b（CCDC： 971 833）属单斜晶系,空间群C12/C1,晶胞参数a=1.411 90（16）nm, b=2.231 4（2）nm, c=1.618 28（18）nm, β=106.904°, V=4.878 1（9） nm³, Dc=1.175 g·cm^-3, Z=1, R₁=0.044 4, wR₂=0.074 6。     

10,10-二苄基-9(10H)蒽醇的酸催化选择性环化反应

蒽酮(1)与3,5-二甲氧基苯甲醛(2)在吡啶/哌啶中反应生成10-(3,5-二甲氧基苯甲亚基蒽酮(3); 3经Pd/C催化氢化生成10-(3,5-二甲氧基苄基蒽酮(4); 4与3-甲氧基苄基氯(5)进行相转移催化烷基化反应生成10-(3,5-二甲氧基苄基)-10-(3-甲氧基苄基)蒽酮(6); 6经NaBH₄还原生成10-(3,5-二甲氧基苄基)-10-(3-甲氧基苄基)-9(10H)-蒽醇(7); 7在酸催化下发生选择性1,7-脱水反应, 生成高三蝶烯(homotriptycene) (8). 其反应机理可能是7在酸存在下生成正碳离子中间体, 然后选择性地亲电进攻富电荷的3,5-二甲氧基苯基, 而不进攻3-甲氧基苯基.     

磷酸特地唑胺的合成新方法

以(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮为起始原料,在[PdCl₂(dppf)]·CH₂Cl₂催化下与联硼酸频那醇酯反应得到硼化物,继而与5-溴-2-(2-甲基-2H-四唑-5-基)吡啶进行Suzuki反应得到特地唑胺,收率82.9%。 分别考察了催化体系对硼化反应和Suzuki反应的影响,确定了较佳的反应条件。 特地唑胺与二苄基N,N-二异丙基亚磷酰胺反应得到二苄基保护的磷酸特地唑胺,随后经Pd/C脱苄得到磷酸特地唑胺,总收率66.2%。     

无催化剂条件下4-羟基烷基-2-炔酸乙酯与N-杂环芳基甲基-N-2,2-二氟乙基-1-胺的串联反应

开发了无催化剂条件下4-羟基烷基-2-炔酸乙酯与N-杂环芳基甲基-N-2,2-二氟乙基-1-胺的串联反应.应用该反应在甲醇中回流,以39%~83%的收率合成了一系列4-(N-(2,2-二氟乙基)(N-杂环芳基甲基)氨基)-5,5-二取代呋喃-2(5H)-酮,其结构经1H NMR,13C NMR和HR-ESI-MS表征,并进一步通过3-氯-4-(N-2,2-二氟乙基)(N-嘧啶-5-基甲基胺基)-5,5-螺(4-甲氧基环己基)呋喃-2(5H)-酮(8)的晶体衍射间接证实.测试了所合成化合物的生物活性,结果表明,在600μg·mL^-1浓度时4-(N-2,2-二氟乙基)(N-6-氯吡啶-3-基甲基胺基)-5,5-二甲基呋喃-2(5H)-酮(3a)和4-(N-2,2-二.氟乙基)(N-6-氟吡啶-3-基甲基胺基)-5,5-二甲基呋喃-2(5H)-酮(3c)对桃蚜的死亡率均为100%.     

3αR-苄基-1-(叔丁基)氧羰基-2-甲基-4,5,6,7-四氢-2H-吡唑并[4,3-c]吡啶-3-(3H)-酮的合成

在O-烯丙基-N-9-蒽甲基溴化辛可宁的催化下,1-苄基-3-乙氧羰基-4-哌啶酮与溴化苄经不对称苄基化反应制得(R)-1,3-二苄基-4-氧代哌啶-3-甲酸乙酯(3); 3脱除Bn保护基并经Boc保护转化为(R)-3-苄基-1-(叔丁基)氧羰基-4-氧代哌啶-3-甲酸乙酯(5); 5与甲基肼在乙醇中经环化反应合成了Capromorelin的关键中间体3αR-苄基-1-(叔丁基)氧羰基-2-甲基-4,5,6,7-四氢-2H-吡唑并[4,3-c]吡啶-3-(3H)-酮,收率70%, ee值69.1%,其结构经¹H NMR, ¹³C NMR和HR-MS（ESI）确证。     

3-甲氧基-6-取代-5,6-二氢吡咯[3,4-b]吡啶-1-酮的合成与生物活性

以3-甲基-2-氰基吡啶为原料,经水解、酯化、硝化、甲氧基取代、溴代反应制得中间体3-溴甲基-5-甲氧基吡啶-2-甲酸甲酯(7),然后中间体与不同的有机胺经环合反应得到一系列新的沙利度胺衍生物3-甲氧基-6-取代-5,6-二氢吡咯[3,4-b]吡啶-7-酮1a~1l.其结构经1H NMR,13C NMR及HRMS确证.采用MTT(噻唑蓝)法测试了目标化合物抑制HCT-116,MG-63,MCF-7,HUVEC及HMVEC细胞的活性,结果表明,几乎所有化合物对人体正常细胞无明显抑制作用,化合物1h~1l只对MG-63细胞株有明显的抑制活性,化合物1c~1g对这三种肿瘤细胞都有较强的抑制活性,其中化合物1d和1e活性最强.     

10-氯-5-二乙氧基甲基-1,3-二甲基色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮的合成和晶体结构

利用L-脯氨酸催化的5-氯水杨醛(1)与6-甲基-4-羟基吡喃酮(2)的缩合反应及硫酸铜催化下与1,3-二甲基-5-氨基吡唑(3)的串联反应,合成得到了10-氯-1,3-二甲基-5-(2-氧代丙基)色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮(4)和10-氯-5-二乙氧基甲基-1,3-二甲基色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮(5).化合物5的结构通过单晶X射线衍射法确定:晶体属于三斜晶系,空间群P-1;相对分子质量Mr=803.68;晶胞参数a=1.03160(10)nm,b=1.42900(13)nm,c=1.44268(15)nm;V=1.9448(3)nm~3;Z=2;晶胞密度Dc=1.372g/cm~3;吸收系数μ=0.228mm-1;单胞中电子的数目F(000)=840.晶体结构用直接法解出,经全矩阵最小二乘法对原子参数进行修正,最终的偏离因子为R=0.0681,w R=0.2051.在晶体结构中色烯环与吡啶环及吡唑环近似于共平面.     

新型氮蒽酮类似物的合成

以2-氯苯甲酸和1-氨基萘为原料制备了7-氯苯并吖啶(3);3分别与吗啉,N-甲基哌嗪,金刚烷胺,2,4-二甲基-6-巯基咪唑,N,N-二甲基乙二胺和5-氨基-3-巯基-1,2,4-三氮唑反应,合成了6个新型的氮蒽酮类似物,其结构经1H NMR和IR表征。     

Coordination networks with fluorinated backbones

Fluorine-containing ligands 2,3,5,6-tetrafluoro-1,4-bis(imidazol-1-yl-methyl)benzene (1) and 2,3,5,6-tetrafluoro-1,4-bis(2-methylimidazol-1-yl-methyl)benzene (2) were prepared and coordinated with AgNO3, Co(ClO4)2 x 6 H2O, and Cd(NO3)2 x 4 H2O, respectively, to form the following structures: 3D channel polymer [Ag2(1)2(NO3)2 x H2O x MeOH]n (3), 2D sheet polymer [Co(1)3(ClO4)2]n (4), 1D chain polymer [Cd(1)3(NO3)2 x 4 H2O]n (5), and a 2D herringbone sheet polymer [Ag(2)NO3 x 1.5 MeOH]n (6). The solid-state crystal structures of 3-6 were studied by single-crystal X-ray crystallography.     

Synthesis of 7a-Aza-benzo[fg]naphthacen-7-one

Phenanthroindolizidine and phenanthroquinolizidine are closely related groups of alkaloids. Since the first isolation of tylophorine 1 in 1935, these natural products have attracted much attention because of their interesting biological activities such as antitumor activity1-3. The obvious problems such as toxicity to nerve system, instability and uneconomical synthetical pathways restrict its application. Kozma reported that C-9, C-14 of tylophorine 1 and C-9, C-15 of cryptopleurine 2 we…     

Synthesis of a New Ligand Containing 1,7—Diaza—12—crown—4 and the Application in Asymmetric Cyclopropanation Reaction

A new chiral multidenate ligand (S,S)-1,7-bis(4-benzyloxazolin-2-yl-methyl)-1,7-diaza-12-crown-4 1 has been synthesized and used as ligand in the copper catalyzed asymmetric cyclopropanation of 1,1-diphenylethylene.     

Gold(I) Complexes with the nido-Diphosphino Ligand [7,8-(Ph(2)P)(2)-7,8-C(2)B(9)H(10)](-). Preparation of the First Metallocarborane Complex of this Ligand. Crystal Structures of [Au{(PPh(2))(2)C(2)B(9)H(10)}(PPh(3))].CH(2)Cl(2) and [Au(2){(PPh(2))(2)C(2)B(9)H(10)}(2){(PPh(2))(2)(CH(2))(3)}].3Me(2)CO

The reaction of [AuCl(PR(3))] with [1,2-(Ph(2)P)(2)-1,2-C(2)B(10)H(10)] in refluxing ethanol proceeds with partial degradation (removal of a boron atom adjacent to carbon) of the closo species to give [Au{(PPh(2))(2)C(2)B(9)H(10)}(PR(3))] [PR(3) = PPh(3) (1), PPh(2)Me (2), PPh(2)(4-Me-C(6)H(4)) (3), P(4-Me-C(6)H(4))(3) (4), P(4-OMe-C(6)H(4))(3) (5)]. Similarly, the treatment of [Au(2)Cl(2)(&mgr;-P-P)] with [1,2-(Ph(2)P)(2)-1,2-C(2)B(10)H(10)] under the same conditions leads to the complexes [Au(2){(PPh(2))(2)C(2)B(9)H(10)}(2)(&mgr;-P-P)] [P-P = dppe = 1,2-bis(diphenylphosphino)ethane (6), dppp = 1,3-bis(diphenylphosphino)propane (7)], where the dppe or dppp ligands bridge two gold nido-diphosphine units. The reaction of 1 with NaH leads to removal of one proton, and further reaction with [Au(PPh(3))(tht)]ClO(4) gives the novel metallocarborane compound [Au(2){(PPh(2))(2)C(2)B(9)H(9)}(PPh(3))(2)] (8). The structure of complexes 1 and 7 have been established by X-ray diffraction. [Au{(PPh(2))(2)C(2)B(9)H(10)}(PPh(3))] (1) (dichloromethane solvate) crystallizes in the monoclinic space group P2(1)/c, with a = 17.326(3) ?, b = 20.688(3) ?, c = 13.442(2) ?, beta = 104.710(12) degrees, Z = 4, and T = -100 degrees C. [Au(2){(PPh(2))(2)C(2)B(9)H(10)}(2)(&mgr;-dppp)] (7) (acetone solvate) is triclinic, space group P&onemacr;, a = 13.432(3) ?, b = 18.888(3) ?, c = 20.021(3) ?, alpha = 78.56(2) degrees, beta = 72.02(2) degrees, gamma = 73.31(2) degrees, Z = 2, and T = -100 degrees C. In both complexes the gold atom exhibits trigonal planar geometry with the 7,8-bis(diphenylphosphino)-7,8-dicarba-nido-undecaborate(1-) acting as a chelating ligand.     

Preparation and characterization of dinuclear Pd(II) complexes of binucleating tetraaza-thiophenolate ligands

The thioethers 4-tert-butyl-2,6-bis((2-(dimethylamino)ethylimino)methyl)phenyl(tert-butyl)sulfane (tBu-L3) and 4-tert-butyl-2,6-bis((2-(dimethylamino)ethylimino)methyl)phenyl(tert-butyl)sulfane (tBu-L4) react with PdCl2(NCMe)2 to give the dinuclear palladium thiophenolate complexes [(L3)Pd2Cl2]+ (2) and [(L4Pd2(mu-Cl)]2+ (3) (HL3= 2,6-bis((2-(dimethylamino)ethylimino)methyl)-4-tert-butylbenzenethiol, HL4 = 2,6-bis((2-(dimethylamino)ethylamino)methyl)-4-tert-butylbenzenethiol). The chloride ligands in could be replaced by neutral (NCMe) and anionic ligands (NCS-, N3-, CN-, OAc-) to give the diamagnetic Pd(II) complexes [(L3)Pd2(NCMe)2]3+ (4), [(L3)Pd2(NCS)2]+ (5), [(L3)Pd2(N3)2]+ (6), [{(L3)Pd2(mu-CN)}2]4+ (7) and [(L3)Pd2(OAc)]2+ (9). The nitrile ligands in and in [(L3)Pd2(NCCH2Cl)2]3+ are readily hydrated to give the corresponding amidato complexes [(L3)Pd2(CH3CONH)]2+ (8) and [(L3)Pd2(CH2ClCONH)]2+ (10). The reaction of [(L3)Pd2(NCMe)2]3+ with NaBPh4 gave the diphenyl complex [(L3)Pd2(Ph)2]+ (11). All complexes were either isolated as perchlorate or tetraphenylborate salts and studied by IR, 1H and 13C NMR spectroscopy. In addition, complexes 2[ClO4], 3[ClO4]2, 5[BPh4], 6[BPh4], 7[ClO4]4, 9[ClO4]2, 10[ClO4]2 and 11[BPh4] have been characterized by X-ray crystallography.     

A New 10—Hydroxyl Anthrone Glycoside from Cassia Siamea Lam.

A new 10-hydroxyl anthrone glycoside,1,8,10-trihydroxyl-1-O-β-D-glucopyranosyl-3-methyl-10-C(S)-β-D-glucopyranosyl-anthrone-9 1 was isolated from the stem of Cassia siamea Lam. The structure was elucidated by spectral evidences, especially by 2D techniques.     

Regiospecific Displacement of the C-B Bond of Tris[4-(substituted)furan-3-yl]boroxines with C-Sn Bond and C-O Bond: Syntheses of 3,4-Disubstituted Furans and 4-Substituted-3(2H)-furanones,

Tris[4-(substituted)furan-3-yl]boroxines 2 , prepared from the corresponding 4-(substituted)-3-(trimethylsilyl) furan 1, were converted successfully to 4-(substituted)-3-(tributylstannyl)furans 3 through palladium-catalyzed cross-coupling reactions with tributylstannyl chloride. Palladium-catalyzed cross-coupling reactions of 3 with organohalides afforded 3,4-disubstituted furans 4 . Regiospecific iodination of 4-(trimethylsilyl)-3-((tributylstannyl) furan ( 3a ) gave 4-iodo-3-(trimethylsilyl)furan ( 5 ), which reacted with excess ethyl acrylate under a common Heck-condition to produce 2,3-bis(trans-ethoxycarbonylvinyl)-4-(trimethylsilyl)furan ( 6 ). A thermal 6-electrocyclic reaction followed by dehydration converted 6 into benzo[2,3-6]furan 8 . Oxidation of 2 generated the corresponding 4-substituted-3(2H)-furanones 9 .     

Tetraaminoperylenes: their efficient synthesis and physical properties

Trimethylsilylation of 1,8-diaminonaphthalene gave 1,8-bis(trimethylsilylamino)naphthalene (1 a), which was in turn lithiated with two molar equivalents of n-butyllithium to give the tris(thf)-solvated dilithium diamide [1,8-[(Me(3)SiN)Li(thf)](2)C(10)H(6)](thf) (2 a). Metal exchange of 2 a with TlCl was carried out in two steps, via the previously characterized mixed-metal amide [1-[(Me(3)SiN)Li(thf)(2)]-8-[(Me(3)SiN)Tl]C(10)H(6)], to give the dithallium diamide [1,8-[(Me(3)SiN)Tl](2)C(10)H(6)] (3 a). Thermolysis of 3 a cleanly gave a 1:1 mixture of the 4,9-bis(trimethylsilylamino)perylenequinone-3,10-bis(trimethylsilylimine) (4 a) and 1 a. By this route, a whole series of silylated homologues of 4 a was obtained in good yields, while the same method proved to be inefficient for the synthesis of the alkyl-substituted analogues. Compound 4 a and its tert-butyldimethylsilyl derivative 4 d were reduced with sodium amalgam to give, after protonation, the corresponding 3,4,9,10-tetraaminoperylenes 7 a and 7 d. Cyclic voltammetry showed two reversible, closely spaced reduction waves (E(red 1)=-1.39, E(red 2)=-1.59 V versus SCE) corresponding to this conversion. The perylenes 7 a and 7 d are thought to be the primary products in the reaction cascade leading to the perylene derivatives, involving the thermal demetalation of the thallium amides, possibly via Tl(II)bond;Tl(II) intermediates, first to give 7 a and its analogues. The final oxidation of the tetraaminoperylenes by one molar equivalent of 3 a and analogous thallium amides gave the quinoidal derivatives such as 4 a and 4 d, a step that could be studied by direct reaction of the isolated species. The UV/Vis absorption spectra of the 4,9-bis(silylamino)perylenequinone-3,10-bis(silylimines) are characterized by a long-wavelength absorption band with a pronounced vibrational structure (lambda(max)=639 nm, lg epsilon =4.53) attributed to a pi*<--pi and a pi*<--n absorption band at 454 nm (lg epsilon 4.83), along with intense absorption in the UV region. A weak red emission with a rather low quantum yield (Phi(fl)=0.001, lambda(max)=660 nm) is observed upon irradiation of a sample; the lifetime of the emission is only 66 ps. The low emission quantum yield is attributed to the *pi<--n transition of the amino perylene, which induces strong spin-orbit coupling, leading to a large triplet yield. The triplet state was probed by transient absorption spectroscopy and found to have a lifetime of 200 ns in air, and 1100 ns in argon-flushed solution. Treatment of 4 a with a stoichiometric amount of KF in methanol/water under phase-transfer conditions (with the cryptand [C 222]) gave an almost quantitative yield of the parent compound 4,9-diaminoperylenequinone-3,10-diimine (8). Treatment of 8 with two molar equivalents of the ruthenium complex [Ru(bpy)(2)(acetone)(2)](PF(6))(2), generated in situ, yielded the blue dinuclear ruthenium complex [(bpy)(4)Ru(2)[mu(2)-N,N':N",N"'-[[4,9-(NH(2))(2)-3,10-(NH)(2)]C(20)H(8)]]](PF(6))(4) (9), the redox properties of which were studied by cyclic voltammetry. The difference in the potentials of the two one-electron redox steps (225 mV) indicates strong coupling of the metal centers through the 4,9-diaminoperylenquinone-3,10-dimine bridging ligand and corresponds to a comproportionation constant K(c) of 6.3 x 10(3). The UV/Vis absorption spectrum of the mixed valent form, which is stable in air, has a characteristic intervalence charge-transfer (IVCT) band in the near infrared at 930 nm (lg epsilon =3.95), from which an electronic coupling parameter J of 760 cm(-1) could be estimated, placing compound 9 at the borderline between the class II and class III cases in the Robin-Day classification.     

Synthesis of indan-based unusual alpha-amino acid derivatives under phase-transfer catalysis conditions

Conformationally constrained cyclic alpha-amino acid derivatives were synthesized under solid-liquid phase-transfer catalysis conditions. This methodology involves the bis-alkylation of ethyl isocyanoacetate with various alpha,alpha'-dibromo-o-xylene derivatives [alpha,alpha'-dibromo-o-xylene 5, 2,3-bis(bromomethyl)-1, 4-dimethoxybenzene 6, 1,2-bis(bromomethyl)-4,5-dibromobenzene 7, 2, 3-bis(bromomethyl)naphthalene 8, 1,8-bis(bromomethyl)-naphthalene 9, 6,7-bis(bromomethyl)-2,2-dimethyl-1H-phenalene-1,3(2H)-dione 10, 2, 3-bis(bromomethyl)-1,4-anthraquinone 11, 6, 7-bis(bromomethyl)quinoxaline 12, 3,4-bis(bromomethyl)furan 13, 1,2, 4,5-tetrakis(bromomethyl)benzene 28, and hexakis(bromomethyl)benzene 30] using potassium carbonate as a base and tetrabutylammonium hydrogensulfate as a phase-transfer catalyst to give corresponding isonitrile derivatives, which upon hydrolysis with HCl in ethanol gave amino esters. Using this method electron-deficient as well as electron-rich and halogen-substituted indan-based alpha-amino acids were prepared. The preparation of bis-indan as well as tris-indan alpha-amino esters is also described.